Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant

28Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

cJun, a major constituent of AP-1 transcription factor transducing multiple mitogen growth signals, is frequently overexpressed in non-small cell lung cancers (NSCLCs). The purpose of this study is to determine the effects of AP-1 blockade on the growth of NSCLC cells using a cJun dominant-negative mutant, TAM67. Transiently transfected TAM67 inhibited AP-1 transcriptional activity in NSCLC cell lines, NCI-H1299 (H1299), A549 and NCI-H520 (H520). The colony-forming efficiency of H1299 and A549 was reduced by TAM67, while that of H520 was not. To elucidate the effects of TAM67 on the growth of H1299, we established H1299 clone cells that expressed TAM67 under the control of a doxycycline-inducible promoter. In the H1299 clone cells, the induced TAM67 inhibited anchorage-dependent growth by promoting G1 cell-cycle block, but not by apoptosis. The induced TAM67 decreased the expression of a cell-cycle regulatory protein, cyclin A. TAM67 also inhibited anchorage-independent growth of these cells. Furthermore, TAM67 reduced growth of established xenograft tumours from these cells in nude mice. These results suggest that AP-1 plays an essential role in the growth of at least some of NSCLC cells. © 2008 Cancer Research UK.

Cite

CITATION STYLE

APA

Shimizu, Y., Kinoshita, I., Kikuchi, J., Yamazaki, K., Nishimura, M., Birrer, M. J., & Dosaka-Akita, H. (2008). Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant. British Journal of Cancer, 98(5), 915–922. https://doi.org/10.1038/sj.bjc.6604267

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free